References
- Steenbergen JN, Alder J, Thorne GM, . Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections. J Antimicrob Chemother 2005;55:283–288.
- CUBICIN [package insert]. Lexington, MA: Cubist Pharmaceuticals, Inc.; August 2008.
- Lodise TP, Graves J, Evans A, . Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin. Antimicrob Agents Chemother 2008;52:3315–3320.
- Holmes NA, Turnidge JD, Munckhof WJ, . Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycn minimum inhibitory concentrations. J Infect Dis 2011;204:340–347.
- Lortholory O, Lefort A, Tod M, . Pharmacodynamics and pharmacokinetics of antibacterial drugs in the management of febrile neutropenia. Lancet 2008;8:612–620.
- Zeitlinger MA, Derendorf H, Mouton JW, . Protein binding: do we ever learn? Antimicrob Agents Chemother 2011;55:3067–3074.
- DeRyke CA, Sutherland C, Zhang B, . Serum bactericidal activities of high-dose daptomycin with and without coadministration of gentamicin against isolates of Staphylococcus aureus and Enterococcus species. Antimicrob Agents Chemother 2006;50:3529–3534.
- Lee DH, Palermo B, Chowdhury M. Successful treatment of methicillin-resistant Staphylococcus aureus meningitis with daptomycin. Clin Infect Dis 2008;47:588–590.
- Kullar R, Chin JN, Parker D, . Pharmacokinetics of single-dose daptomycin in patients with suspected or confirmed neurological infections. Antimicrob Agents Chemother 2011;55:3505–3509.
- Goedecke VA, Clajus C, Burkhardt O, . Pharmacokinetics and dialysate levels of daptomycin given intravenously in a peritoneal dialysis patient. Scan J Infect Dis 2009;41:155–157.
- Sader HS, Jones RN. Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007–2008). Diagn Microbiol Infect Dis 2009;65:158–162.
- Le J, Bookstaver PB, Rudisill CN. Treatment of meningitis caused by vancomycin-resistant Enterococcus faecium: high dose and combination daptomycin therapy. Ann Pharmacother 2010;44: 2001–2006.
- Gerber P, Stucki A, Acosta F, . Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis. J Antimicrob Chemother 2006;57: 720–723.
- Safdar N, Andes D, Craig WA. In vivo pharmacodynamic activity of daptomycin. Antimicrob Agents Chemother 2004;48:63–68.
- Pankey G, Ashcraft D, Patel N. In vitro synergy of daptomycin plus rifampin against Enterococcus faecium resistant to both linezolid and vancomycin. Antimicrob Agents Chemother 2005;49:5166–5168.
- Rand KH, Houch H. Daptomycin synergy with rifampicin and ampicillin against vancomycin-resistant enterococci. J Antimicrob Chemother 2004;53:530–532.